Global search

Find data and evidence

Type at least 2 characters. Use arrow keys to review and Enter to open.

Peer reviewedOpen accessSmallpoxMonkeypox

Long-term consequences of monkeypox virus infection or modified vaccinia virus Ankara vaccination in Belgium (MPX-COHORT and POQS-FU-PLUS): a 24-month prospective and retrospective cohort study

The Lancet Infectious Diseases·

Christophe Van Dijck, Nicole Berens-Riha, Luca M Zaeck, Cécile Kremer, Jacob Verschueren, Jasmine Coppens, Fien Vanroye, Elisabeth Willems, Evi Bosman, Natalie De Cock, Bart Smekens, Leen Vandenhove, Odin Goovaerts, Anke Van Hul, Janne Wouters, Bart K M Jacobs, Stefanie Bracke, Matilde Hens, Isabel Brosius, Elise De Vos, Eugene Bangwen, Sarah Houben, Achilleas Tsoumanis, Pedro Henrique Lopes Ferreira Dantas, Jojanneke Rutgers, Amber Lipman, Koen Wijnans, Patrick Soentjens, Emmanuel Bottieau, Chris Kenyon, Johan van Griensven, Thijs Reyniers, Niels Horst, Kevin K Ariën, Marjan Van Esbroeck, Andrea Torneri, Koen Vercauteren, Wim Adriaensen, Rory D de Vries, Joachim Mariën, Laurens Liesenborghs

DOI
10.1016/s1473-3099(25)00545-6
PMID
41213280
PMCID
OpenAlex
W4416019668
Study type
Cohort study
Publisher
Elsevier BV
Article type
journal-article
Integrity
current

Why this research matters now

The observed differences in immune durability between natural infection and vaccination highlight potential considerations for maintaining population-level protection against circulating orthopoxviruses.

01

Structured evidence summary

Research question

The investigation evaluates persistent clinical effects following mpox infection and compares the durability of immune responses generated by natural exposure versus MVA-BN immunization.

Study design

A mixed retrospective and prospective cohort framework tracked participants across a twenty-four-month period with scheduled assessments at eight, sixteen, and twenty-four months.

Population and setting

Adult participants recruited in Belgium, predominantly identifying as men with a median age of forty, included individuals recovering from acute mpox and those receiving the specified vaccine.

Main findings

Physical sequelae such as scarring persisted in a subset of infected individuals through the two-year mark, while other initial symptoms generally diminished within twelve months. Laboratory testing revealed no detectable viral genetic material in oral, anorectal, or semen samples during follow-up periods. Immunological assays indicated that prior infection produced more sustained binding antibody levels compared to the vaccine-induced response observed at eight months.

Public-health relevance

The observed differences in immune durability between natural infection and vaccination highlight potential considerations for maintaining population-level protection against circulating orthopoxviruses.

Important limitations

Attendance rates decreased substantially over the twenty-four-month observation window, potentially introducing attrition bias. Furthermore, this assessment depends entirely on the provided abstract and metadata, requiring the complete manuscript for decision-grade interpretation.

GIDS interpretation

This publication provides longitudinal observational data relevant to orthopoxvirus epidemiology and immunogenicity research. It establishes a baseline reference for monitoring viral clearance patterns and comparative vaccine performance without implying real-time outbreak tracking.

02

Related GIDS surveillance

Literature context does not validate, explain, or change a surveillance signal. Exact and contextual relationships are shown separately.

03

Evidence relationships

This article has 9 auditable classifier relationships to diseases, places, topics, and study design.

about diseaseabout diseaseaddresses topicevaluates interventionhas pathogen typestudied instudied population settingstudies pathogenuses study design